MedTrace Logo

Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy

NCT00781001 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2013-07-30

No results posted yet for this study

Summary

The purpose of this study is to determine if vaporized cannabis is effective as an analgesic for the treatment of painful diabetic neuropathy.

Conditions

  • Painful Diabetic Neuropathy

Interventions

DRUG

Cannabis

400mg placebo or active cannabis administered via the Volcano vaporizer 1x per study visit

Sponsors & Collaborators

  • Center for Medicinal Cannabis Research

    lead OTHER

Principal Investigators

  • Mark S Wallace, M.D. · University of California, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00781001 on ClinicalTrials.gov